CAPSOVISION INC (CV) — insider trading
Health Care · NASDAQ
CAPSOVISION INC (CV) has 17 reported SEC Form 4 insider transactions in our data, including 2 open-market purchases and 1 open-market sale among the most recent 17 (latest 2026-07-08).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-08 | HARARI ELIYAHOU ET AL | 10% owner | Open-market purchase | 81,300 | $6.09 | $495.1K | Form 4 |
| 2026-07-01 | Shields David Stanley | Director | Grant / award / vesting (derivative) | 1,710 | $0.00 | $0 | Form 4 |
| 2026-06-30 | GOUW JULIA S | Director | Option exercise / conversion (derivative) | 2,022 | $0.00 | $0 | Form 4 |
| 2026-06-30 | GOUW JULIA S | Director | Option exercise / conversion | 2,022 | $7.58 | $15.3K | Form 4 |
| 2026-06-30 | Harari Michele | Director | Option exercise / conversion (derivative) | 2,022 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Harari Michele | Director | Option exercise / conversion | 2,022 | $7.58 | $15.3K | Form 4 |
| 2026-06-30 | King Wen-Herng Henry | Director | Option exercise / conversion (derivative) | 2,022 | $0.00 | $0 | Form 4 |
| 2026-06-30 | King Wen-Herng Henry | Director | Option exercise / conversion | 2,022 | $7.58 | $15.3K | Form 4 |
| 2026-06-30 | Kuo Hui Ying | Director | Option exercise / conversion (derivative) | 2,022 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Kuo Hui Ying | Director | Option exercise / conversion | 2,022 | $7.58 | $15.3K | Form 4 |
| 2026-06-30 | Tsai Chen Lung | Director | Option exercise / conversion (derivative) | 2,022 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Tsai Chen Lung | Director | Option exercise / conversion | 2,022 | $7.58 | $15.3K | Form 4 |
| 2026-06-30 | Imperial Joanne Carol | Director | Option exercise / conversion (derivative) | 2,022 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Imperial Joanne Carol | Director | Option exercise / conversion | 2,022 | $7.58 | $15.3K | Form 4 |
| 2026-06-26 | HARARI ELIYAHOU ET AL | 10% owner | Open-market purchase | 13,850 | $7.35 | $101.8K | Form 4 |
| 2026-06-08 | Imperial Joanne Carol | Director | Open-market sale | 1,200 | $7.16 | $8.6K | Form 4/A |
| 2026-06-01 | Wang Kang-Huai | Director, Officer (See Remarks) | Grant / award / vesting (derivative) | 358,344 | $0.00 | $0 | Form 4 |
Ask the chat about CV's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CAPSOVISION INC (CV).
Last updated 2026-07-08 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.